Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study
Top Cited Papers
- 1 May 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9319) , 1740-1745
- https://doi.org/10.1016/s0140-6736(02)08655-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitusDiabetologia, 2001
- Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populationsDiabetologia, 2001
- IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.Diabetes, 2000
- Insulin-Like Growth Factor-I in Diabetes Mellitus: Its Physiology, Metabolic Effects, and Potential Clinical UtilityDiabetes Technology & Therapeutics, 2000
- Insulin-Like Growth Factor Binding Proteins: New Proteins, New FunctionsHormone Research in Paediatrics, 1999
- Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitusMetabolism, 1998
- Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormoneInternational Journal of Obesity, 1997
- Dual Hormonal Replacement With Insulin and Recombinant Human Insulin-Like Growth Factor I in IDDM: Effects on glycemic control, IGF-I levels, and safety profileDiabetes Care, 1997
- Treatment of type A insulin resistance with insulin-like growth factor-IThe Lancet, 1993
- Sensitive Amplified Immunoenzymometric Assays (IEMA) for Human Insulin and Intact Proinsulincclm, 1992